Search - tctmd.com

Displaying 201 - 220 of 449

Sort: Relevancy | Date

News Daily News

Supplemental Oxygen Not Beneficial in MI Patients With Normal O2 Levels: Meta-analysis

Michael O'Riordan

April 11, 2018

News Daily News

Varenicline Boosts Long-term Quit Rate in Post-ACS Smokers: EVITA

Caitlin E. Cox

March 26, 2018

News Conference News ACC 2018

High CRP Linked to Bigger Absolute Drops in CV Events for Patients Taking Evolocumab

Michael O'Riordan

March 20, 2018

News Daily News

For CHD Patients, Physical Activity More Meaningful Than Weight Changes Over Time

Caitlin E. Cox

March 13, 2018

News Conference News ACC 2018

Too Soon for 6-Month DAPT, Say SMART-DATE Investigators, Despite Positive Trial

Yael L. Maxwell

March 12, 2018

News Daily News

‘Weekend Effect’ Still a Reality for ACS Patients in Italy

Caitlin E. Cox

March 06, 2018

News Conference News ACC 2018

ACC 2018: More PCSK9 Outcomes, Antiplatelet Insights, and LifeVest Data at Last

Shelley Wood

March 05, 2018

News Conference News ACC 2018

Flu Vaccine Reduces Mortality, Hospitalization in HF Patients: Meta-analysis

Michael O'Riordan

March 01, 2018

News Daily News

Early Invasive Strategy Linked to Worse QoL in Elderly NSTEMI Patients

L.A. McKeown

January 23, 2018

News Daily News

Women Have Higher Risk of Unplanned Readmission After PCI

Michael O'Riordan

January 12, 2018

News Daily News

PCI Comparable to CABG in Left Main Coronary Disease: Meta-analysis

Michael O'Riordan

December 14, 2017

News Features

Trajectory Unknown: How ORBITA Lands in Clinical Practice Still Up for Debate

Michael O'Riordan

November 27, 2017

News Daily News

Radial Access Best for PCI Following Thrombolysis in STEMI

Michael O'Riordan

November 27, 2017

News Daily News

Routine Coronary CTA to Rule Out ACS in Acute Chest Pain Questioned in ROMICAT-II Subanalysis

L.A. McKeown

November 21, 2017

News Conference News TCT 2017

DES With Bioresorbable Polymer Outperforms BMS in SENIOR Patients

Michael O'Riordan

November 01, 2017

News Conference News TCT 2017

VAMPIRE 3: Attenuated Plaque May Signal Benefit of Thrombus Removal in PCI

Shelley Wood

November 01, 2017

News Conference News TCT 2017

Live From Denver: TCT 2017, Day One

Shelley Wood

October 30, 2017

News Conference News TCT 2017

No Late Quality of Life Trade-offs With PCI in Left Main Disease: EXCEL-QOL Substudy

Michael O'Riordan

October 30, 2017

News Daily News

Secondary Prevention Lagging Behind in Women With Established Coronary Disease

Todd Neale

September 22, 2017

News Conference News ESC 2017

Ultra-Low LDL Levels? FOURIER Suggests Efficacy of Evolocumab

Michael O'Riordan

August 28, 2017

Advertisement

Supplemental Oxygen Not Beneficial in MI Patients With Normal O2 Levels: Meta-analysis

Varenicline Boosts Long-term Quit Rate in Post-ACS Smokers: EVITA

High CRP Linked to Bigger Absolute Drops in CV Events for Patients Taking Evolocumab

For CHD Patients, Physical Activity More Meaningful Than Weight Changes Over Time

Too Soon for 6-Month DAPT, Say SMART-DATE Investigators, Despite Positive Trial

‘Weekend Effect’ Still a Reality for ACS Patients in Italy

ACC 2018: More PCSK9 Outcomes, Antiplatelet Insights, and LifeVest Data at Last

Flu Vaccine Reduces Mortality, Hospitalization in HF Patients: Meta-analysis

Early Invasive Strategy Linked to Worse QoL in Elderly NSTEMI Patients

Women Have Higher Risk of Unplanned Readmission After PCI

PCI Comparable to CABG in Left Main Coronary Disease: Meta-analysis

Trajectory Unknown: How ORBITA Lands in Clinical Practice Still Up for Debate

Radial Access Best for PCI Following Thrombolysis in STEMI

Routine Coronary CTA to Rule Out ACS in Acute Chest Pain Questioned in ROMICAT-II Subanalysis

DES With Bioresorbable Polymer Outperforms BMS in SENIOR Patients

VAMPIRE 3: Attenuated Plaque May Signal Benefit of Thrombus Removal in PCI

Live From Denver: TCT 2017, Day One

No Late Quality of Life Trade-offs With PCI in Left Main Disease: EXCEL-QOL Substudy

Secondary Prevention Lagging Behind in Women With Established Coronary Disease

Ultra-Low LDL Levels? FOURIER Suggests Efficacy of Evolocumab

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content